Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Smith Nephew ADR Representing 2 Ord Shs C.SNN


Primary Symbol: SNN

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.


NYSE:SNN - Post by User

Comment by sunrizeon Sep 24, 2018 4:00pm
155 Views
Post# 28680312

RE:RE:RE:Bought deal 3,800,000 Units at a price of $5.27 per Unit

RE:RE:RE:Bought deal 3,800,000 Units at a price of $5.27 per Unit The only thing that is certain with SNN sp is this:
When good news comes (not IF) the sp move up will be violent. Think Pampalona.

Good news can be one or more of the following:
1. Debt financing approved for Canada (after spinout)
2. Substantial increase in revenues from NHS/Extraction facility
3. Inking a deal(s) (beverage or tobacco company)

https://media.giphy.com/media/1qn8a2l8pImOs/giphy.gif

Joeknowsjack wrote: When comparing valuations there is no other mjn company that trades at a bigger discount than Sunniva....how long will sale price last.... Current projects...phase 1 325000sq ft campus in california...phase 2 164000 Sq ft. 759000sq ft campus in Okanagan BC And they own Natural Health Services Ltd. ("NHS") NHS owns and operates a network of seven clinics in Canada specializing in medical cannabis under ACMPR. NHS connects patients with safe and effective medical cannabis products through LPs. NHS has in-house physicians and nurse practitioners specializing in the endocannabinoid system providing expert consultation, education, and recommendations for patients. NHS' proprietary technology infrastructure assists physicians, patients and LPs to comply with the rules of Health Canada. And company plans to list on nasdaq and tsx come October......


<< Previous
Bullboard Posts
Next >>